Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Colostrum and whey could have a role in TB control
dairy cows
High sensitivity tests may be key to bTB eradication, researchers say.
Australian researchers highlight the importance of high sensitivity tests

Colostrum and colostral whey could have an important role to play in the control and eradication of bovine TB in the UK, according to researchers from the University of Adelaide in Australia.

Writing in the Veterinary Record letters, researchers from the university's School of Animals and Veterinary Sciences, said recent research has underlined the need for tests with high diagnostic sensitivity.

A new test for alpacas may even have applications for cattle, they said. The recently launched multiplex TB immunoassay shows superior sensitivity compared to the intradermal test for alpacas.

Recent research on Johne's disease in vaccinated sheep also found that using colostrum or colostral whey showed a significant increase in antibody ELISA sensitivity.

"We are not aware of any current research in the UK on bovine TB or Johne's disease using colostrum or colostral whey to parameterise antibody assays and wish to draw attention to the potential of these samples to increase diagnostic sensitivities," they wrote

"Colostrum is readily available on dairy farms and is easy to collect and store. Current bovine TB and Johne's disease research projects may be able to incorporate the collection of colostrum without major additional expense."

The full letter can be found in Vet Record Vol 175 No 23.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.